 Katrina Claw
Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 CYP2A6 | 5 | 2021 | 11 | 1.990 |
Why?
| | Indians, North American | 7 | 2021 | 600 | 1.850 |
Why?
| | Nicotine | 5 | 2024 | 289 | 1.430 |
Why?
| | Evolution, Molecular | 4 | 2018 | 458 | 1.180 |
Why?
| | Genomics | 5 | 2022 | 726 | 1.120 |
Why?
| | Neanderthals | 1 | 2023 | 11 | 0.910 |
Why?
| | Pharmacogenetics | 2 | 2023 | 159 | 0.850 |
Why?
| | Hominidae | 1 | 2023 | 99 | 0.840 |
Why?
| | Genetic Research | 2 | 2020 | 20 | 0.800 |
Why?
| | Paleontology | 2 | 2022 | 21 | 0.780 |
Why?
| | Genotype | 6 | 2021 | 1960 | 0.750 |
Why?
| | Cytochrome P-450 CYP2B6 | 1 | 2020 | 10 | 0.720 |
Why?
| | Alaska Natives | 4 | 2021 | 120 | 0.640 |
Why?
| | Semen | 1 | 2018 | 25 | 0.620 |
Why?
| | Health Services, Indigenous | 1 | 2018 | 32 | 0.610 |
Why?
| | Community Participation | 2 | 2018 | 125 | 0.610 |
Why?
| | DNA | 1 | 2023 | 1406 | 0.560 |
Why?
| | Genetic Variation | 4 | 2020 | 970 | 0.500 |
Why?
| | Membrane Glycoproteins | 2 | 2014 | 454 | 0.480 |
Why?
| | Sperm-Ovum Interactions | 1 | 2014 | 12 | 0.470 |
Why?
| | Immunoglobulins | 1 | 2014 | 155 | 0.450 |
Why?
| | Smoking | 2 | 2024 | 1635 | 0.440 |
Why?
| | Alaska | 3 | 2021 | 85 | 0.410 |
Why?
| | Proteomics | 1 | 2018 | 903 | 0.410 |
Why?
| | Glycoproteins | 1 | 2014 | 330 | 0.410 |
Why?
| | DNA, Ancient | 3 | 2022 | 7 | 0.380 |
Why?
| | Oocytes | 1 | 2012 | 194 | 0.380 |
Why?
| | Research | 3 | 2020 | 440 | 0.370 |
Why?
| | Receptors, Serotonin, 5-HT2 | 1 | 2010 | 3 | 0.350 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 44 | 0.340 |
Why?
| | Haplotypes | 2 | 2019 | 496 | 0.340 |
Why?
| | Smoking Cessation | 3 | 2024 | 398 | 0.340 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2010 | 74 | 0.340 |
Why?
| | Membrane Proteins | 1 | 2014 | 1089 | 0.300 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2021 | 2135 | 0.300 |
Why?
| | Liver | 5 | 2018 | 1872 | 0.290 |
Why?
| | Humans | 26 | 2024 | 125131 | 0.240 |
Why?
| | Biological Evolution | 2 | 2023 | 459 | 0.230 |
Why?
| | Computational Biology | 2 | 2019 | 616 | 0.230 |
Why?
| | Australia | 1 | 2023 | 228 | 0.210 |
Why?
| | Pharmacogenomic Testing | 2 | 2021 | 55 | 0.210 |
Why?
| | Spermatozoa | 2 | 2014 | 93 | 0.210 |
Why?
| | Ethics Committees, Research | 2 | 2018 | 48 | 0.190 |
Why?
| | Genome, Human | 1 | 2023 | 396 | 0.190 |
Why?
| | Cultural Competency | 2 | 2018 | 80 | 0.190 |
Why?
| | Xenobiotics | 1 | 2021 | 25 | 0.190 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2021 | 63 | 0.180 |
Why?
| | Tissue Banks | 2 | 2018 | 19 | 0.180 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2019 | 25 | 0.170 |
Why?
| | Animals | 7 | 2023 | 34345 | 0.160 |
Why?
| | Linkage Disequilibrium | 3 | 2021 | 288 | 0.160 |
Why?
| | Glucuronosyltransferase | 1 | 2018 | 10 | 0.160 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2019 | 468 | 0.150 |
Why?
| | Sulfotransferases | 1 | 2018 | 6 | 0.150 |
Why?
| | Population Groups | 1 | 2018 | 57 | 0.150 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2018 | 43 | 0.150 |
Why?
| | Calcifediol | 1 | 2018 | 30 | 0.150 |
Why?
| | Oxygenases | 1 | 2017 | 10 | 0.150 |
Why?
| | Sulfates | 1 | 2018 | 46 | 0.150 |
Why?
| | Researcher-Subject Relations | 1 | 2017 | 4 | 0.150 |
Why?
| | Primates | 1 | 2018 | 114 | 0.140 |
Why?
| | New Mexico | 1 | 2017 | 70 | 0.140 |
Why?
| | Reproduction | 1 | 2018 | 195 | 0.140 |
Why?
| | Androgens | 1 | 2018 | 169 | 0.140 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 363 | 0.140 |
Why?
| | Adult | 8 | 2024 | 33167 | 0.140 |
Why?
| | Middle Aged | 7 | 2021 | 29112 | 0.130 |
Why?
| | Disease Susceptibility | 1 | 2018 | 343 | 0.130 |
Why?
| | Women | 1 | 2016 | 54 | 0.130 |
Why?
| | Urban Population | 1 | 2018 | 433 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 431 | 0.130 |
Why?
| | Microsomes, Liver | 3 | 2021 | 62 | 0.130 |
Why?
| | Health Services Research | 1 | 2018 | 384 | 0.130 |
Why?
| | Male | 9 | 2021 | 60792 | 0.120 |
Why?
| | Young Adult | 6 | 2021 | 11384 | 0.120 |
Why?
| | Mass Spectrometry | 1 | 2018 | 699 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2018 | 767 | 0.120 |
Why?
| | Phylogeny | 1 | 2018 | 823 | 0.120 |
Why?
| | Vitamin D | 1 | 2018 | 362 | 0.120 |
Why?
| | Ovum | 1 | 2014 | 30 | 0.120 |
Why?
| | Haplorhini | 1 | 2014 | 63 | 0.120 |
Why?
| | Biomedical Research | 1 | 2020 | 641 | 0.120 |
Why?
| | Public Health | 1 | 2018 | 493 | 0.110 |
Why?
| | Cell Adhesion Molecules | 1 | 2014 | 182 | 0.110 |
Why?
| | Zona Pellucida Glycoproteins | 1 | 2012 | 2 | 0.100 |
Why?
| | Zona Pellucida | 1 | 2012 | 3 | 0.100 |
Why?
| | Egg Proteins | 1 | 2012 | 19 | 0.100 |
Why?
| | Aged | 6 | 2021 | 20859 | 0.100 |
Why?
| | Adolescent | 6 | 2021 | 19411 | 0.100 |
Why?
| | Fertilization | 1 | 2012 | 43 | 0.100 |
Why?
| | Communication | 1 | 2017 | 801 | 0.100 |
Why?
| | Receptors, Cell Surface | 1 | 2012 | 368 | 0.090 |
Why?
| | Aged, 80 and over | 5 | 2021 | 6936 | 0.090 |
Why?
| | Pan troglodytes | 1 | 2010 | 57 | 0.090 |
Why?
| | Female | 8 | 2021 | 64889 | 0.080 |
Why?
| | Cell Membrane | 1 | 2012 | 732 | 0.080 |
Why?
| | Gene Frequency | 2 | 2021 | 528 | 0.080 |
Why?
| | Infant | 5 | 2021 | 8625 | 0.080 |
Why?
| | Selection, Genetic | 1 | 2010 | 256 | 0.080 |
Why?
| | alpha-Amylases | 1 | 2007 | 17 | 0.070 |
Why?
| | Child, Preschool | 5 | 2021 | 9938 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2021 | 9790 | 0.070 |
Why?
| | Alleles | 2 | 2021 | 865 | 0.070 |
Why?
| | Infant, Newborn | 4 | 2021 | 5456 | 0.070 |
Why?
| | Gene Dosage | 1 | 2007 | 136 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1042 | 0.070 |
Why?
| | Nicotinic Agonists | 1 | 2024 | 113 | 0.050 |
Why?
| | Child | 5 | 2021 | 20014 | 0.050 |
Why?
| | Informed Consent | 1 | 2022 | 172 | 0.050 |
Why?
| | Enzyme Assays | 1 | 2021 | 25 | 0.050 |
Why?
| | Pharmacogenomic Variants | 1 | 2021 | 35 | 0.050 |
Why?
| | Research Personnel | 1 | 2022 | 166 | 0.040 |
Why?
| | Dextrorphan | 1 | 2019 | 2 | 0.040 |
Why?
| | Dextromethorphan | 1 | 2019 | 22 | 0.040 |
Why?
| | Metoprolol | 1 | 2019 | 37 | 0.040 |
Why?
| | Foster Home Care | 1 | 2020 | 79 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2017 | 2753 | 0.040 |
Why?
| | United States Indian Health Service | 1 | 2018 | 43 | 0.040 |
Why?
| | Inactivation, Metabolic | 1 | 2018 | 11 | 0.040 |
Why?
| | Capacity Building | 1 | 2018 | 54 | 0.040 |
Why?
| | Hydroxylation | 1 | 2018 | 28 | 0.040 |
Why?
| | Genetic Loci | 1 | 2019 | 299 | 0.040 |
Why?
| | Information Dissemination | 1 | 2020 | 229 | 0.040 |
Why?
| | Receptors, Steroid | 1 | 2018 | 54 | 0.040 |
Why?
| | Research Support as Topic | 1 | 2018 | 123 | 0.040 |
Why?
| | Community-Based Participatory Research | 1 | 2018 | 138 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2019 | 391 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2018 | 113 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2018 | 169 | 0.040 |
Why?
| | Umbelliferones | 1 | 2016 | 1 | 0.040 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 2016 | 11 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1006 | 0.030 |
Why?
| | Health Status Disparities | 1 | 2018 | 222 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 669 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2016 | 102 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1144 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2016 | 299 | 0.030 |
Why?
| | Testosterone | 1 | 2018 | 357 | 0.030 |
Why?
| | Kinetics | 1 | 2018 | 1680 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 2913 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2017 | 699 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1530 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1403 | 0.020 |
Why?
| | Starch | 1 | 2007 | 25 | 0.020 |
Why?
| | Aging | 1 | 2017 | 1706 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 5348 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 13708 | 0.020 |
Why?
| | United States | 1 | 2018 | 13613 | 0.010 |
Why?
| | Diet | 1 | 2007 | 1178 | 0.010 |
Why?
|
|
Claw's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|